v3.26.1
Condensed Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Series B Convertible Preferred Stock [Member]
Preferred Stock [Member]
May 2025 Private Placement [Member]
Series B Convertible Preferred Stock [Member]
Preferred Stock [Member]
At The Market Offering [Member]
Series B Convertible Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Registered Direct Offering [Member]
Common Stock [Member]
Renovaro Extension Agreement [Member]
Common Stock [Member]
May 2025 Private Placement [Member]
Common Stock [Member]
At The Market Offering [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Registered Direct Offering [Member]
Additional Paid-in Capital [Member]
Renovaro Extension Agreement [Member]
Additional Paid-in Capital [Member]
May 2025 Private Placement [Member]
Additional Paid-in Capital [Member]
At The Market Offering [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Registered Direct Offering [Member]
Retained Earnings [Member]
Renovaro Extension Agreement [Member]
Retained Earnings [Member]
May 2025 Private Placement [Member]
Retained Earnings [Member]
At The Market Offering [Member]
Retained Earnings [Member]
Registered Direct Offering [Member]
Renovaro Extension Agreement [Member]
May 2025 Private Placement [Member]
At The Market Offering [Member]
Total
Balance (in shares) at Dec. 31, 2024     79,246         444,475                              
Balance at Dec. 31, 2024     $ 792         $ 4,445         $ 180,218,424         $ (180,426,271)         $ (202,610)
Issuance of shares pursuant to Warrant Inducement Transaction, net of issuance costs (in shares)               95,601                              
Issuance of shares pursuant to Warrant Inducement Transaction, net of issuance costs               $ 956         1,533,426         0         1,534,382
Net loss                         0         (2,442,873)         (2,442,873)
Issuance of shares pursuant to At The Market Offering, net of issuance costs (in shares)       24,223 31,153                                    
Issuance of shares pursuant to At The Market Offering, net of issuance costs       $ 242 $ 312       $ 465,063 $ 499,688       $ 0 $ 0       $ 465,305 $ 500,000      
Net loss                         0         (2,442,873)         (2,442,873)
Balance (in shares) at Mar. 31, 2025     79,246         595,452                              
Balance at Mar. 31, 2025     $ 792         $ 5,955         182,716,601         (182,869,144)         (145,796)
Balance (in shares) at Dec. 31, 2024     79,246         444,475                              
Balance at Dec. 31, 2024     $ 792         $ 4,445         180,218,424         (180,426,271)         (202,610)
Net loss                                             (4,513,335)
Net loss                                             (4,513,335)
Balance (in shares) at Jun. 30, 2025     79,246         639,798                              
Balance at Jun. 30, 2025     $ 792         $ 6,399         183,279,017         (184,939,606)         (1,653,398)
Balance (in shares) at Mar. 31, 2025     79,246         595,452                              
Balance at Mar. 31, 2025     $ 792         $ 5,955         182,716,601         (182,869,144)         (145,796)
Issuance of shares to non-employees (in shares)               6,667                              
Issuance of shares to non-employees               $ 67         99,933         0         100,000
Net loss                                   (2,070,462)         (2,070,462)
Issuance of shares pursuant to At The Market Offering, net of issuance costs (in shares) 0         18,692 18,987                                
Issuance of shares pursuant to At The Market Offering, net of issuance costs $ 0         $ 187 $ 190       $ 299,813 $ 162,670       $ 0 $ 0       $ 300,000 $ 162,860  
Net loss                                   (2,070,462)         (2,070,462)
Balance (in shares) at Jun. 30, 2025     79,246         639,798                              
Balance at Jun. 30, 2025     $ 792         $ 6,399         183,279,017         (184,939,606)         (1,653,398)
Balance (in shares) at Dec. 31, 2025     79,246         4,083,173                              
Balance at Dec. 31, 2025     $ 792         $ 40,832         461,196,805         (413,521,474)         47,716,955
Share-based compensation related to instruments granted to employees                         111,358         0         111,358
Issuance of common stock, net, in connection with restricted stock units vesting (in shares)               13,242                              
Issuance of common stock, net, in connection with restricted stock units vesting               $ 132         (17,576)         0         (17,444)
Issuance of shares to non-employees (in shares)               23,613                              
Issuance of shares to non-employees               $ 237         168,597         0         168,833
Issuance of shares pursuant to Warrant Inducement Transaction, net of issuance costs (in shares)               1,419,239                              
Issuance of shares pursuant to Warrant Inducement Transaction, net of issuance costs               $ 14,193         (14,192)         0         1
Net loss                         0         (7,708,943)         (7,708,943)
Net loss                         0         (7,708,943)         (7,708,943)
Balance (in shares) at Mar. 31, 2026     79,246         5,539,267                              
Balance at Mar. 31, 2026     $ 792         $ 55,394         461,444,992         (421,230,417)         40,270,761
Balance (in shares) at Dec. 31, 2025     79,246         4,083,173                              
Balance at Dec. 31, 2025     $ 792         $ 40,832         461,196,805         (413,521,474)         47,716,955
Net loss                                             (24,914,825)
Net loss                                             (24,914,825)
Balance (in shares) at Jun. 30, 2026     79,246         11,384,940                              
Balance at Jun. 30, 2026     $ 792         $ 113,849         472,366,853         (438,436,299)         34,045,195
Balance (in shares) at Mar. 31, 2026     79,246         5,539,267                              
Balance at Mar. 31, 2026     $ 792         $ 55,394         461,444,992         (421,230,417)         40,270,761
Share-based compensation related to instruments granted to employees                         571,584         0         571,584
Issuance of common stock, net, in connection with restricted stock units vesting (in shares)               26,393                              
Issuance of common stock, net, in connection with restricted stock units vesting               $ 264         (56,941)         0         (56,677)
Issuance of shares to non-employees (in shares)     0         27,984                              
Issuance of shares to non-employees     $ 0         $ 279         129,006         0         129,285
Issuance of shares pursuant to Warrant Inducement Transaction, net of issuance costs (in shares)     0         4,727,432                              
Issuance of shares pursuant to Warrant Inducement Transaction, net of issuance costs     $ 0         $ 47,274         (47,274)         0         0
Net loss               0         0         (17,205,882)         (17,205,882)
Issuance of shares pursuant to At The Market Offering, net of issuance costs (in shares)   0         1,063,864                                
Issuance of shares pursuant to At The Market Offering, net of issuance costs   $ 0         $ 10,638         $ 10,325,486         $ 0         $ 10,336,124  
Net loss               $ 0         0         (17,205,882)         (17,205,882)
Balance (in shares) at Jun. 30, 2026     79,246         11,384,940                              
Balance at Jun. 30, 2026     $ 792         $ 113,849         $ 472,366,853         $ (438,436,299)         $ 34,045,195